Literature DB >> 26644281

Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys.

Robert E Brutcher1, Susan H Nader1, Michael A Nader2.   

Abstract

There are several case reports of nonmedicinal quetiapine abuse, yet there are very limited preclinical studies investigating quetiapine self-administration. The goal of this study was to investigate the reinforcing effects of quetiapine alone and in combination with intravenous cocaine in monkeys. In experiment 1, cocaine-experienced female monkeys (N = 4) responded under a fixed-ratio (FR) 30 schedule of food reinforcement (1.0-g banana-flavored pellets), and when responding was stable, quetiapine (0.003-0.1 mg/kg per injection) or saline was substituted for a minimum of five sessions; there was a return to food-maintained responding between doses. Next, monkeys were treated with quetiapine (25 mg, by mouth, twice a day) for approximately 30 days, and then the quetiapine self-administration dose-response curve was redetermined. In experiment 2, male monkeys (N = 6) self-administered cocaine under a concurrent FR schedule with food reinforcement (three food pellets) as the alternative to cocaine (0.003-0.3 mg/kg per injection) presentation. Once choice responding was stable, the effects of adding quetiapine (0.03 or 0.1 mg/kg per injection) to the cocaine solution were examined. In experiment 1, quetiapine did not function as a reinforcer, and chronic quetiapine treatment did not alter these effects. In experiment 2, cocaine choice increased in a dose-dependent fashion. The addition of quetiapine to cocaine resulted in increases in low-dose cocaine choice and number of cocaine injections in four monkeys, while not affecting high-dose cocaine preference. Thus, although quetiapine alone does not have abuse potential, there was evidence of enhancement of the reinforcing potency of cocaine. These results suggest that the use of quetiapine in cocaine-addicted patients should be monitored.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26644281      PMCID: PMC4727159          DOI: 10.1124/jpet.115.228577

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  47 in total

1.  Intranasal quetiapine abuse.

Authors:  Joseph M Pierre; Igor Shnayder; Donna A Wirshing; William C Wirshing
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

2.  Self-administration of cocaine-antihistamine combinations: super-additive reinforcing effects.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

3.  Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs.

Authors:  Vera C Campbell; Theresa A Kopajtic; Amy Hauck Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2005-07-29       Impact factor: 4.030

4.  Characterization of the dopamine receptor system in adult rhesus monkeys exposed to cocaine throughout gestation.

Authors:  Lindsey R Hamilton; Paul W Czoty; H Donald Gage; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2010-04-20       Impact factor: 4.530

5.  Additional evidence of the abuse potential of quetiapine.

Authors:  Roy R Reeves; James C Brister
Journal:  South Med J       Date:  2007-08       Impact factor: 0.954

6.  Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey.

Authors:  J W McKearney
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  The relationship between cocaine self-administration and actigraphy-based measures of sleep in adult rhesus monkeys.

Authors:  Robert E Brutcher; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2013-04-21       Impact factor: 4.530

Review 8.  The misuse/abuse of antihistamine antiemetic medication (cyclizine) by cancer patients.

Authors:  F Bailey; A Davies
Journal:  Palliat Med       Date:  2008-08-21       Impact factor: 4.762

9.  Sleep-promoting properties of quetiapine in healthy subjects.

Authors:  Stefan Cohrs; Andrea Rodenbeck; Zhenghua Guan; Kathrin Pohlmann; Wolfgang Jordan; Andreas Meier; Eckart Rüther
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

10.  Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.

Authors:  Martha Sajatovic; Jamie A Mullen; Dennis E Sweitzer
Journal:  J Clin Psychiatry       Date:  2002-12       Impact factor: 4.384

View more
  1 in total

Review 1.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.